| 7.83 BATS BZX Real-Time Price As of 10:31am ET |  +0.14 / +1.82%Today’s Change | 7.46 Today|||52-Week Range 25.96 | -49.22% Year-to-Date |
| Previous close | 7.69 |
| Today’s open | 7.67 |
| Day’s range | 7.62 - 7.86 |
| Volume | 3,332,021 |
| Average volume (3 months) | 16,394,783 |
| Market cap | $8.6B |
| Earnings growth (last year) | +85.71% |
| Earnings growth (this year) | -18.97% |
| Earnings growth (next 5 years) | +1.85% |
| Revenue growth (last year) | -16.69% |
| P/E ratio | NM |
| Price/Sales | 0.84 |
| Price/Book | 0.58 |
| Today’s change | Today’s % change | |
|---|---|---|
| BGNEBeiGene Ltd | +1.65 | +1.27% |
| BBIOBridgeBio Pharma Inc | -0.87 | -2.88% |
| AKRXAkorn Inc | -0.03 | -0.79% |
| OASMOasmia Pharmaceutica... | -0.02 | -1.08% |
| Next reporting date | August 7, 2019 |
| EPS forecast (this quarter) | $0.57 |
| Annual revenue (last year) | $18.8B |
| Annual profit (last year) | -$2.1B |
| Net profit margin | -11.40% |
Sector Health Technology |
Industry Pharmaceuticals: Generic |
President, Chief Executive Officer & Director Kåre Schultz |
Executive Vice President- Global Operations Carlo de Notaristefani |
Corporate headquarters Petach Tikva, Hamerkaz |
